

Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|11|3|236-238
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.11, Iss.3, 2011-03, pp. : 236-238
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 2, 2011-01 ,pp. :